Operate stage hub · Africa and India

Operate a Pharmaceutical Manufacturing Facility

Run people, materials, facilities, equipment, laboratories, records and release decisions as one connected GMP operating system—from demand to dependable supply.

By S. BHATTIReviewed 27 October 2026Medium-to-large manufacturing sites

Open the operating cycle Use the 90-day plan

THE DAILY CONTROL TOWER

01PlanDemand, capacity, materials and cash agree.

02PreparePeople, assets, areas and documents are ready.

03ExecuteThe process is followed and recorded as performed.

04VerifyIndependent evidence supports disposition and supply.

05LearnSignals become action, knowledge and stronger control.

The operating principle

Control the system—not only the production line.

Pharmaceutical operations convert an approved product, facility and quality system into repeated evidence that every batch remains suitable for its intended use. Output matters, but it is acceptable only when product quality, data integrity, regulatory commitments and supply reliability remain under control.

This hub connects the decisions that are often managed separately. It is a practical operating map, not a substitute for national law, approved registrations, validated processes, product-specific controls or authorized company procedures.

One site · three simultaneous obligations

Quality, flow and evidence must move together.

Protect the patient and product

Prevent mix-ups, contamination, deterioration, incorrect processing and unsupported release.

Deliver reliable supply

Plan capacity, materials, testing, maintenance and cash so compliant supply is repeatable rather than heroic.

Preserve trustworthy evidence

Record what happened, retain raw data, investigate uncertainty and make decisions that can withstand review.

The end-to-end operating cycle

Eight control loops from demand to improvement.

Each loop has an operational question, minimum actions and evidence that must be visible before the next decision is trusted.

Loop01

Plan demand, capacity and cash

What must be supplied—and what constraints could make that plan unsafe or unrealistic?

Translate demand into product, batch, campaign and packaging plans
Check registered packs, shelf life, customer commitments and changeovers
Model material lead times, QC capacity, working capital and release timing
Approve a frozen near-term schedule with controlled changes

Loop02

Secure and release inputs

Are every material, supplier, specification, status decision and storage condition ready?

Use approved suppliers and controlled purchase specifications
Plan imports, foreign exchange, transit, sampling and test lead time
Maintain quarantine, released, rejected and returned status segregation
Verify identity, expiry or retest date, FEFO and dispensing readiness

Loop03

Prepare people, areas and assets

Can the scheduled work start without relying on assumptions or workarounds?

Confirm trained and qualified people for each critical task
Verify cleaning, line clearance, environmental status and area readiness
Confirm equipment qualification, calibration, maintenance and change parts
Issue current master documents and reconcile controlled components

Loop04

Execute and record the batch

Is the process being followed, observed and recorded as it actually occurs?

Follow approved instructions and defined in-process controls
Record contemporaneously and preserve attributable raw data
Escalate deviations, alarms, atypical trends and yield concerns promptly
Control hold times, reconciliation, labels, samples and status movement

Loop05

Test, review and release

Does independent evidence support the proposed material or batch disposition?

Use approved sampling plans, methods, standards and qualified instruments
Review calculations, chromatographic data, audit trails and atypical results
Complete production, packaging, laboratory and deviation review
Make release or rejection decisions through authorized Quality personnel

Loop06

Store, distribute and monitor

Will released product remain suitable and traceable through the supply chain?

Control storage, dispatch, transport, customers and distribution records
Monitor stability, complaints, returns, adverse-event interfaces and recalls
Protect pack identity, security, temperature and remaining shelf life
Maintain rapid batch and customer traceability

Loop07

Investigate, change and recover

When reality differs from the plan, is risk contained and the decision scientifically justified?

Contain product, data and process risk before searching for cause
Investigate deviations, OOS results, complaints and recurring signals
Assess changes against validation, registrations, supply and training
Define CAPA ownership, due dates, effectiveness criteria and escalation

Loop08

Review, learn and improve

Is management using evidence to protect control, capability and supply?

Trend process, product, laboratory, supplier and reliability signals
Complete product-quality and pharmaceutical-quality-system reviews
Review quality objectives, risks, resources, recurring failures and capacity
Approve improvements and confirm their intended results

The site operating model

Twelve systems—one accountable operation.

Departmental boundaries should clarify ownership without breaking the flow of materials, information, evidence and decisions.

Site leadership and PQS

Set priorities, decision rights, quality objectives, risk appetite, management review and escalation.

Production

Convert master instructions into controlled dispensing, processing, in-process control, cleaning and yield evidence.

Packaging

Control line clearance, printed components, coding, reconciliation, tamper evidence and final pack identity.

Warehouse and supply

Plan, receive, status, sample, store, issue, reconcile, dispatch and trace materials and products.

Quality assurance

Maintain independent oversight, records, batch review, disposition, events, changes, audits and quality governance.

QC and microbiology

Control samples, methods, standards, instruments, raw data, investigations, stability and laboratory capacity.

Engineering and utilities

Keep facilities, HVAC, water, power, compressed air, equipment, calibration and spares reliable.

Validation and technology

Maintain process knowledge, qualification, validation, transfer, continued verification and lifecycle evidence.

People and competence

Translate roles into staffing, induction, task qualification, supervision, observation and retraining.

Data and digital systems

Govern paper and electronic records, access, master data, audit trails, backup, interfaces and cybersecurity.

EHS and site security

Control occupational, process, environmental, waste, emergency, access and product-security risks.

Regulatory and commercial interface

Keep licences, dossiers, artwork, commitments, forecasts and customer requirements aligned with operations.

One batch · one evidence chain

The batch begins before dispensing and continues after release.

Weak handoffs create hidden risk. Make the input, output, owner, status and escalation rule visible at every transition.

01
Demand
Approved product, market, pack, quantity and delivery need
02
Plan
Feasible campaign, batch, material, people, asset and QC schedule
03
Inputs
Released materials, current documents and controlled components
04
Prepare
Qualified people, clean area, suitable utilities and ready equipment
05
Make
Controlled processing, IPCs, hold times, yields and deviations
06
Pack
Correct components, coding, reconciliation and line clearance
07
Test
Representative samples, valid methods, complete raw data and review
08
Release
Independent review of the complete batch and quality history
09
Supply
Controlled storage, dispatch, traceability and feedback

Decision rights and escalation

Make authority explicit before pressure arrives.

A role may perform the work, another may review it, and only a defined authority may approve the decision. Production urgency must never silently rewrite those rights.

Decision	Accountable authority	Minimum evidence	Escalate when
Freeze or change the production schedule	Operations planning with Production, Warehouse, QC and QA	Feasible materials, capacity, release and customer-impact review	A change threatens validated sequencing, expiry, test capacity or supply
Issue a material or component	Authorized Warehouse under Quality-approved status controls	Identity, status, quantity, expiry/retest, FEFO and dispensing check	Status is unclear, damaged, expired, discrepant or not approved
Start a batch or packaging line	Authorized Production/Packaging supervision	Area, equipment, people, document, material and line-clearance readiness	Any prerequisite is missing or relies on an undocumented workaround
Continue after an unexpected event	Defined operational authority with QA escalation	Immediate assessment, containment and documented instruction	Potential impact to product, patient, data, validation or another batch
Invalidate a laboratory result	Authorized laboratory and Quality investigation process	Documented assignable cause supported by evidence	No conclusive laboratory cause or wider manufacturing risk exists
Release, reject or place a batch on hold	Authorized Quality unit	Complete reviewed record, specifications, deviations and regulatory commitments	Records, investigations, data or market requirements remain unresolved
Implement a change	Change-control approval authority	Risk, validation, regulatory, document, training and implementation evidence	The intended state or post-implementation acceptance is not demonstrated
Stop supply or initiate recall assessment	Defined quality and executive escalation team	Patient/product risk, traceability, market information and authority obligations	Potentially distributed affected product or uncertain batch/market scope

Management operating cadence

Use the right meeting for the right time horizon.

Short-interval control should solve today's risk. Management review should address system performance, resources and recurring causes—not repeat the daily meeting at a slower pace.

Every shift

Control the work now

Safety and quality signals
Plan versus actual
Area/equipment status
Material and staffing constraints
Events and handover actions

Daily

Protect flow and decisions

Batch and release queue
Deviations/OOS/escalations
QC turnaround
Maintenance/utilities
Customer-critical risks

Weekly

Remove systemic constraints

Schedule adherence
Material coverage
Yield and right-first-time
CAPA/change backlog
People and asset capacity

Monthly / quarterly

Review the system

Quality and process trends
Supplier performance
Validation and stability
PQR/APR programme
Objectives, resources and management actions

A balanced control room

Measure what helps people act—not what merely looks green.

Every measure needs a definition, owner, source, frequency, threshold and action rule. Pair output and speed with quality, recurrence, ageing and effectiveness so teams are not rewarded for hiding risk or closing records prematurely.

Patient and product

Critical deviations
OOS and atypical trends
Complaints and returns
Batch rejection
Recall/field-action signals

Control and compliance

Right-first-time records
CAPA/change ageing
Training effectiveness
Audit recurrence
Data-integrity signals

Flow and supply

Schedule adherence
Release lead time
OTIF supply
Material shortages
QC turnaround time

Capability and cost

Yield and reconciliation
OEE by constraint
Breakdown/downtime
Utility reliability
Cost of poor quality

Africa–India operating realities

Design daily control around the constraints that actually exist.

Resilience does not lower the GMP standard. It makes the required control executable when supply, infrastructure, service capacity or cash conversion is uncertain.

Imported inputs and foreign exchange

Separate demand from confirmed supply. Track forex, purchase, shipment, customs, sampling, testing and usable-release dates for APIs, excipients, printed components and spares.

Power, water and utility resilience

Define what must continue, what may stop safely and how excursions are assessed. Back-up systems need capacity, fuel, maintenance, alarms, testing and recovery procedures.

Vendor service and critical spares

Risk-rank equipment and utilities, define minimum stock, preserve drawings and passwords, and build local competence where overseas response times could stop production.

Workforce capability

Use supervised task qualification and observation, not certificates or attendance alone. Protect scarce technical roles through succession, cross-training and retention.

Regulatory and dossier alignment

National requirements and approved product commitments govern. Keep formulae, suppliers, methods, sites, artwork and process parameters aligned with registrations and controlled variations.

Public procurement and market volatility

Distinguish forecast, tender, award, purchase order and cash receipt. Avoid committing capacity and working capital to demand that has not reached an executable commercial stage.

Common operating failures

Recognize the pattern before it becomes normal work.

Failure pattern	What it creates	Better operating control
The schedule outranks the control strategy	People bypass holds, clearances or investigations to recover output.	Define non-negotiable stop conditions and make schedule recovery a cross-functional decision.
QA becomes the final inspection department	Quality problems are discovered at batch release rather than prevented during execution.	Place ownership with the process while preserving independent Quality oversight and disposition.
Passing results hide weak operations	A compliant COA is treated as proof that records, process and data were in control.	Review the full batch history, deviations, trends and data integrity before disposition.
Maintenance is driven by breakdowns	Production pressure consumes planned maintenance until failures become normal.	Risk-rank assets, protect preventive work and review recurrence, spares and root causes.
SOP count is mistaken for maturity	Procedures multiply while workarounds, weak supervision and poor records continue.	Simplify instructions, observe execution and measure competence and process performance.
KPIs reward the wrong behaviour	Output, closure or on-time percentages improve while risk is hidden or records are closed prematurely.	Pair speed and volume measures with quality, recurrence, ageing and effectiveness measures.
Events are closed but not learned from	Repeat deviations receive isolated CAPAs and management sees no systemic pattern.	Code causes and systems consistently, trend recurrence and review effectiveness at management level.

Implementation sequence

A practical 90-day operating-system reset.

For an existing facility, begin by exposing the real work, then stabilize daily control, and only then formalize the improvement agenda.

Days 1–30

See the real system

Map products, flows and constraints
Walk each shift and value stream
Confirm licences and dossier commitments
Baseline quality, delivery and reliability signals
List critical risks and unclear decision rights

Days 31–60

Stabilize daily control

Establish shift and daily tier meetings
Create one constraint and escalation log
Clarify batch, event and release ownership
Protect maintenance, calibration and QC capacity
Close the most immediate control gaps

Days 61–90

Build the improvement loop

Install the balanced scorecard
Trend repeat failures and ageing
Confirm CAPA effectiveness logic
Align weekly and management review
Approve the next 90-day improvement plan

Connected guides and tools

Move from the operating map into the control you need.

Batch Record Review and Product Release

Connect batch evidence to independent review and authorized disposition.

Open resource

Batch Review and Release Readiness Workbook

Assess 30 prerequisites across five review stages.

Open resource

Warehouse and Materials Management

Control receipt, quarantine, Quality release, storage, dispensing and reconciliation.

Open resource

Material Receipt, Storage and Dispensing Readiness Workbook

Assess 40 material controls across five decision gates.

Open resource

Production Planning and Shop-Floor Control

Convert qualified demand into feasible campaigns, evidence-based starts, controlled execution and released supply.

Open resource

Batch and Campaign Readiness Workbook

Assess 64 production and release controls across eight decision gates and expose unresolved blockers.

Open resource

Pharmaceutical Technology Transfer

Move product, process, analytical and regulatory knowledge into controlled commercial manufacture.

Open resource

Technology Transfer Readiness Workbook

Assess 64 evidence controls across eight transfer gates and expose unresolved blockers.

Open resource

Pharmaceutical Quality System

See how monitoring, CAPA, change, management review, risk and knowledge connect.

Open resource

GMP Foundations

Translate requirements into ownership, controls, evidence and shop-floor routines.

Open resource

Good Documentation Practices

Build records that reliably reconstruct manufacturing and laboratory work.

Open resource

Data Integrity and ALCOA+

Apply reliable-data principles to paper, electronic and hybrid processes.

Open resource

GMP Training Effectiveness

Move from attendance to demonstrated task competence and sustained performance.

Open resource

Deviation and OOS Investigations

Structure containment, evidence, cause, impact and disposition decisions.

Open resource

Process Validation

Maintain product and process knowledge through continued verification.

Open resource

Quality Systems Toolkit

Use practical checklists and workbooks across investigations, suppliers, validation and records.

Open resource

New production-control cluster

Move from qualified demand to a released batch without hiding the constraint.

Use the complete guide to design the planning and shop-floor operating system, then apply the interactive workbook to assess campaign evidence, decision gates and unresolved blockers.

Read the production-planning guide Open the readiness workbook Return to the Operate pathway

Primary framework references

Accessed 27 October 2026. Always confirm the current national law, licence conditions, approved marketing-authorisation commitments and product-specific requirements for each site and market.

Educational notice: This hub provides general education and operating-system guidance. Batch disposition, GMP, validation, engineering, safety, regulatory and product decisions require authorized personnel working within the applicable law and approved pharmaceutical quality system.